Access cutting-edge breast cancer treatment through this clinical trial at a research site in Santa Barbara. Study-provided care at no cost to qualified participants.
Access breast cancer specialists in Santa Barbara at no cost
This study follows strict safety protocols and ethical guidelines
All study-related breast cancer treatment provided free
A Phase Ib/III Open-label, Randomised Study of Capivasertib plus CDK4/6 Inhibitors and Fulvestrant versus CDK4/6 Inhibitors and Fulvestrant in Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced, Unresectable or Metastatic Breast Cancer (CAPItello-292)
Sponsor: AstraZeneca
Check if you qualify for this breast cancer clinical trial in Santa Barbara, CA
If you're searching for breast cancer treatment options in Santa Barbara, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Santa Barbara research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.